Serum chemokine levels differentially regulated by vorinostat in a Sézary syndrome patient.

Serum chemokine levels differentially regulated by vorinostat in a Sézary syndrome patient.
复制标题

伏立诺他对塞扎里综合征患者血清趋化因子水平的差异调节。

DOI:
10.1111/bjd.13696
复制
发表时间:
2015
期刊:
British journal pf dermatology
影响因子:
--
通讯作者:
Sato S
Sato S
中科院分区:
--
文献类型:
--
作者:
Miyagaki T;Sugaya M;Oka T;Fujita H;Sato S

文献摘要

相似文献

3 Sviggum HP,Davis MD,Rajkumar SV,Dispenzieri A.来那度胺治疗淀粉样变性和多发性骨髓瘤的皮肤病不良反应。皮肤病学文献2006; 142:1298-302. 4 Michot C、Guillot B、Dereure O。来那度胺诱导的头颈部急性痤疮样毛囊炎:不仅是抗EGF受体药物。皮肤病学2010; 220:49-50。5 Gilaberte Y,Coscojuela C,Vazquez C等.与类风湿性关节炎给予的肿瘤坏死因子-α抑制剂相关的穿孔性毛囊炎。英国皮肤病学杂志2007; 156:368-71。6 Noman AS,Koide N,Khuda II et al. Thalidomide inhibits epidermal growth factor-induced cell growth in mouse and human monocytic leukemia cells via Ras inactivation.生物化学和生物物理研究通讯2008; 374:683-7.
3 Sviggum HP, Davis MD, Rajkumar SV, Dispenzieri A. Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma. Arch Dermatol 2006; 142: 1298–302. 4 Michot C, Guillot B, Dereure O. Lenalidomide-induced acute acneiform folliculitis of the head and neck: not only the anti-EGF receptor agents. Dermatology 2010; 220: 49–50. 5 Gilaberte Y, Coscojuela C, Vazquez C et al. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis. Br J Dermatol 2007; 156: 368–71. 6 Noman AS, Koide N, Khuda II et al. Thalidomide inhibits epidermal growth factor-induced cell growth in mouse and human monocytic leukemia cells via Ras inactivation. Biochem Biophys Res Commun 2008; 374: 683–7.